BioSpace News Archive

Business

Sapience Therapeutics to Participate at SVB Leerink Biopharma Private Company Connect

Sapience Therapeutics, Inc. announced today it was invited to participate as one of a select group of companies at SVB Leerink’s Biopharma Private Company Connect, taking place virtually on July 21-22nd, 2021.

July 15, 2021
·
2 min read
BioForest

Volpara Health Grows Patent Collection with Recently Granted European Protection of Image Quantification

Volpara has recently been granted another patent by the European Patent Office, raising the total number of patents for the New Zealand-based health tech company to 98.

July 15, 2021
·
3 min read
Business

Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results

Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 5, 2021, at 4:30 p.m. Eastern Time to review 2021 second quarter financial results.

July 15, 2021
·
1 min read
Pharm Country

Evergreen Theragnostics Expands Alpha Radiopharmaceutical Production Capabilities

Evergreen Theragnostics, Inc., a leading radiopharmaceutical Contract Development and Manufacturing Organization, has undertaken an important strategic expansion at its manufacturing facility in Springfield, NJ

July 15, 2021
·
3 min read
Deals

HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company

HeartFlow announced today that they have entered into a definitive business combination agreement that will support HeartFlow’s vision of revolutionizing precision heart care.

July 15, 2021
·
17 min read
Business

Amneal to Report Second Quarter 2021 Results on August 9, 2021

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to market open.

July 15, 2021
·
2 min read
Business

Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to Its Board of Directors

Candel Therapeutics, Inc. today announced it has appointed Diem Nguyen, Ph.D., M.B.A., to its Board of Directors.

July 15, 2021
·
3 min read
Genetown

CANbridge Pharmaceuticals CAN106 Investigational New Drug Application Approved in China for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

CANbridge Pharmaceuticals Inc. announced that the Chinese National Medical Products Administration (NMPA) has approved an Investigational New Drug (IND) application for CAN106, a long-acting humanized monoclonal antibody targeting complement C5 of the complement system.

July 15, 2021
·
3 min read
Business

ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021

IMMUNOPRECISE ANTIBODIES LTD. today announced the Company will host a conference call to discuss its financial results and business highlights for the full fiscal year 2021.

July 15, 2021
·
2 min read